Thornhill Therapeutics is a preclinical biotechnology company developing an oral delivery platform for biologic drugs
Thornhill Therapeutics is a preclinical biotechnology company developing an oral delivery platform for biologic drugs. Its formulation and delivery technology aims to improve the stability and absorption of biologics and enable injectable therapies to be administered orally. Its pipeline includes Cholix-IL10 for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.